A new criterion to assess distributional homogeneity in hyperspectral images of solid pharmaceutical dosage forms

During galenic formulation development, homogeneity of distribution is a critical parameter to check since it may influence activity and safety of the drug. Raman hyperspectral imaging is a technique of choice for assessing the distributional homogeneity of compounds of interest. Indeed, the combination of both spectroscopic and spatial information provides a detailed knowledge of chemical composition and component distribution.     

Electroanalysis of antitubercular drugs in pharmaceutical dosage forms and biological fluids: A review

Tuberculosis remains a major global public health problem. Given the need for extensive analysis of antitubercular drugs, the development of sensitive, reliable and facile analytical methods to determine these compounds becomes necessary. Electrochemical techniques have inherent advantages over other well-established analytical methods, this review aiming to provide an updated overview of the latest trends (from 2006 till date) in the voltammetric determination of antitubercular drugs. Furthermore, the advantages and limitations of these methods are critically discussed. The review reveals that in spite of using a variety of chemically modified electrodes to determine antitubercular drugs, there is still a dearth of applicability of the voltammetric methods to quantify these compounds in human body fluids, especially in blood plasma.     

HPLC‐DAD method for the simultaneous determination of zofenopril and hydrochlorothiazide in oral pharmaceutical formulations

An HPLC method with DAD detection was developed and validated for the simultaneous determination of zofenopril and hydrochlorothiazide in tablets. The separation was carried out through a gradient elution using an Agilent LiChrospher C18 column (250×4.0 mm id, 5 μm) and a mobile phase consisting of (A) water–TFA (99.9:0.1 v/v) and (B) acetonitrile–TFA (99.1:0.1 v/v) delivered at a flow‐rate of 1.0 mL/min. 8‐Chlorotheophylline was used as internal standard. Calibration curves were found to be linear for the two drugs over the concentration ranges of 5.0–40 and 1.0–20 μg/mL for zofenopril and hydrochlorothiazide, respectively. Linearity, precision, accuracy, specificity and robustness were determined in order to validate the proposed method, which was further applied to the analysis of commercial tablets. The proposed method is simple and rapid, and gives accurate and precise results.     

Content uniformity of pharmaceutical solid dosage forms by near infrared hyperspectral imaging: A feasibility study

Near-infrared imaging systems simultaneously record spectral and spatial information. Each measurement generates a data cube containing several thousand spectra. Chemometric methods are therefore required to extract qualitative and quantitative information. The aim of this study was to determine the feasibility of quantifying active pharmaceutical ingredient (API) and excipient content in pharmaceutical formulations using hyperspectral imaging.Two kinds of tablets with a range of API content were analysed: a binary mixture of API and cellulose, and a pharmaceutical formulation with seven different compounds. Two pixel sizes, 10 μm/pixel and 40 μm/pixel, were compared, together with two types of spectral pretreatment: standard normal variate (SNV) normalization and Savitzky-Golay smoothing. Two methods of extracting concentrations were compared: the partial least squares 2 (PLS2) algorithm, which predicts the content of several compounds simultaneously, and the multivariate classical least squares (CLS) algorithm based on pure compound reference spectra without calibration.Best content predictions were achieved using 40 μm/pixel resolution and the PLS2 method with SNV normalized spectra. However, the CLS method extracted distribution maps with higher contrast and was less sensitive to noisy spectra and outliers; its API predictions were also highly correlated to real content, indicating the feasibility of predicting API content using hyperspectral imaging without calibration.     

A new non-invasive, quantitative Raman technique for the determination of an active ingredient in pharmaceutical liquids by direct measurement through a plastic bottle

The concentration of an active pharmaceutical ingredient (povidone) in a commercial eyewash solution has been measured directly through a plastic (low-density polyethylene: LDPE) container using a wide area illumination (WAI) Raman scheme. The WAI scheme allows excitation using a 6 mm laser spot (focal length: 248 mm) that is designed to cover a wide sample area. As a result, it has the potential to improve the reliability Raman measurements by significantly enhancing representative sample interrogation, thus improving the reproducibility of sampling. It also decreases the sensitivity of sample placement with regard to the excitation focal plane. Simultaneously, isobutyric anhydride was placed in front of the bottles to use for a synchronous external standard configuration. This helps to correct the problematic variation of Raman intensity from the inherent fluctuation in laser power. Using the WAI Raman scheme combined with the synchronous standard method, the povidone concentration was successfully measured with spectral collection that was performed through a plastic barrier. The conventional Raman scheme was difficult to employ for the same purpose because of the degraded spectral reproducibility resulting from the smaller laser illumination area and the sensitivity of such an approach to the position of the sample bottle. The result from this study suggests that the WAI scheme exhibits a strong potential for the non-destructive quantitative analysis of pharmaceuticals measured directly in plastic containers. Preliminary work also shows that similar measurements can also be made in glass bottles. If implemented, this technique could be utilized as a simple and rugged method for quality assurance of final products in a manner consistent with Process analytical technology (PAT) requirements.     

A novel application of immobilization on membranes for the separation and spectrofluorimetric quantification of amiloride and furosemide in pharmaceutical samples

A new, simple and highly sensitive method for spectrofluorimetric determination of amiloride (AMI) and furosemide (FUR) in pharmaceuticals is presented. The proposed method is based on the separation of AMI from FUR by solid-phase extraction using a nylon membrane, followed by spectrofluorimetric determination of both drugs, on the solid surface and the filtered aqueous solution, respectively. AMI shows low native fluorescence, but its separation-preconcentration by immobilization (solid-phase extraction) on nylon membrane surface provides a considerable enhancement in fluorescence intensity. The fluorescence determination is carried out at λ_ex = 237, λ_em = 415 nm for FUR; and λ_ex = 365, λ_em = 406 nm for AMI. The calibration graphs are linear in the range 3.20 × 10⁻⁴ to 0.8 μg mL⁻¹and 1.33 × 10⁻³ to 4.0 μg mL⁻¹, for AMI and FUR, respectively, with a detection limit of 9.62 × 10⁻⁵ and 4.01 × 10⁻⁴ μg mL⁻¹ (S/N = 3). The commonly found excipients in commercial pharmaceutical formulations do not interfere. The developed method is successfully applied to the determination of both drugs in pharmaceutical formulations.     

A review on solid phase microextraction-high performance liquid chromatography as a novel tool for the analysis of toxic metal ions

This paper reviews the practical applications of solid phase microextraction-High performance liquid chromatography in the analysis of toxic metal species as these are important contaminants and are carcinogenic. Their determination in formulations, in feed and food, and in complex environmental matrices (e.g., waste water and industrial effluents) often requires analytical methods capable of high efficiency, unique selectivity, and high sensitivity. Solid phase microextraction (SPME) requires low solvent consumption and is quick in use. SPME is used for extraction and online desorption of analytes with the mobile phase of HPLC and subsequent detection by UV, ICP-MS or ESI-MS as detectors. Different SPME-HPLC methods are summarized in this article to demonstrate the usefulness of this technique for metallic species of As, Cr, Pb, Hg and Se.     

馏分油浆态床加氢处理研究: II FCC柴油加氢工艺条件及动力学研究

对FCC柴油在浆态床柴油加氢催化剂SP25上的加氢工艺条件进行了优化,并考察了加氢脱硫（HDS）和加氢脱氮（HDN）动力学。结果表明,提高反应温度、提高反应压力、增加催化剂的加入量、延长反应时间都能提高催化剂的加氢精制活性,最佳的FCC柴油浆态床加氢工艺条件为,温度350℃、压力6MPa、催化剂加入量6%、反应时间2h。催化剂循环使用性能的考察结果表明,SP25催化剂具有良好的活性稳定性。动力学研究结果表明,FCC柴油的加氢脱硫反应过程可以分为两个阶段。第一阶段为较易脱除的苯并噻吩类（BTs）硫化物的加氢脱硫反应,反应活化能为70.00kJ/mol;第二阶段为较难脱除的二苯并噻吩类（DBTs）硫化物的加氢脱硫反应,反应活化能为85.65kJ/mol。FCC柴油HDN反应的活化能为79.91kJ/mol。烷基取代的二苯并噻吩类硫化物（特别是DMDBTs）是加氢精制反应中最难脱除的含杂原子（S或N）烃类化合物。